We are live on
!
Find out more
TCA
Transcend Capital Advisors Portfolio holdings
AUM
$1.25B
1-Year Est. Return
17.69%
This Fund
S&P 500
This Quarter
Est. Return
-2.97%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
–
AUM
$1.03B
AUM Growth
-$22.9M
(-2.2%)
Cap. Flow
+$10.3M
Cap. Flow
% of AUM
1%
Top 10 Holdings %
Top 10 Hldgs %
29.21%
Holding
518
New
31
Increased
189
Reduced
206
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$10M |
| 2 |
Zoom
ZM
|
+$5.79M |
| 3 |
iShares US Medical Devices ETF
IHI
|
+$2.55M |
| 4 |
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
|
+$2.34M |
| 5 |
iShares National Muni Bond ETF
MUB
|
+$1.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 10-20 Year Treasury Bond ETF
TLH
|
+$3.94M |
| 2 |
CANO
Cano Health, Inc.
CANO
|
+$2.29M |
| 3 |
iShares Global Consumer Staples ETF
KXI
|
+$2.14M |
| 4 |
State Street SPDR Nuveen ICE Municipal Bond ETF
TFI
|
+$2.05M |
| 5 |
WisdomTree Floating Rate Treasury Fund
USFR
|
+$1.68M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.17% |
| 2 | Financials | 17.11% |
| 3 | Healthcare | 10.22% |
| 4 | Consumer Discretionary | 4.85% |
| 5 | Communication Services | 3.39% |
Similar funds
GGS
LIA
LMGAM
CPA
ODIJL
FFM
TCA
DP
Transcend Capital Advisors's Q3 2023 Portfolio in Review
As of Q3 2023, Transcend Capital Advisors held 518 positions worth $1.03B, down 2.2% from $1.05B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Transcend Capital Advisors's Q3 2023 filing shows 31 new, 189 increased, 206 reduced and 28 closed positions. Its largest new stake was iShares US Medical Devices ETF: 47,945 shares worth $2.33M. The largest sale was iShares 10-20 Year Treasury Bond ETF, an estimated $3.94M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Financials and Healthcare.
- Transcend Capital Advisors's largest Q3 2023 buy was iShares US Medical Devices ETF: 47,945 shares worth $2.33M.
- Transcend Capital Advisors added most to Johnson & Johnson in Q3 2023, an estimated $10M increase.
- Transcend Capital Advisors's biggest Q3 2023 reduction was iShares 10-20 Year Treasury Bond ETF, cutting an estimated $3.94M.
- Transcend Capital Advisors fully exited State Street SPDR Nuveen ICE Municipal Bond ETF in Q3 2023, selling an estimated $2.05M.
- Transcend Capital Advisors's ten largest holdings make up 29% of its $1.03B portfolio in Q3 2023.
- Transcend Capital Advisors opened 31 new positions and closed 28 in Q3 2023.
- Transcend Capital Advisors's portfolio value fell 2.2% quarter-over-quarter to $1.03B.
Based on Transcend Capital Advisors's 13F filing for Q3 2023, filed 31 Oct 2023.